Graf Akcie IONS (Ionis Pharmaceuticals Inc). Diskuze k akciím IONS. Aktuální informace IONS.

Základní informace o společnosti Ionis Pharmaceuticals Inc (Akcie IONS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 4.86B
Hodnota podniku (EV) 4.37B
Tržby 687.717M
EBITDA -205.26
Zisk -541.96
Růst v tržbách Q/Q -13.60 %
Růst v tržbách Y/Y -26.88 %
P/E (Cena vůči ziskům) N/A
Forward P/E 145.12
EV/Sales 6.36
EV/EBITDA N/A
EV/EBIT N/A
PEG 25.70
Price/Sales 7.06
P/FCF N/A
Price/Book 5.76
Účetní hodnota na akcii 6.18
Hotovost na akcii 13.86
FCF vůči ceně -1.09 %
Počet zaměstnanců 757
Tržba na zaměstnance 908.477k
Profit margin -61.88 %
Operating margin -32.59 %
Gross margin 98.36 %
EBIT margin -28.13 %
EBITDA margin -29.85 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 147.83 %
EPS - Očekávaný růst příští rok 118.18 %
Return on assets -21.19 %
Return on equity -62.12 %
ROIC -3.31 %
ROCE -8.78 %
Dluhy/Equity 1.83
Čistý dluh/EBITDA 20.41
Current ratio 7.62
Quick Ratio 7.54
Volatilita 3.18
Beta 1.05
RSI 52.72
Cílová cena analytiků 67
Známka akcie (dle analytiků) 2.45
Insider ownership 4.87 %
Institutional ownership 87.40 %
Počet akcií 141.148M
Procento shortovaných akcií 9.12 %
Short ratio 4.83 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1991
Země United States

Finanční výsledky akcie IONS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$729.264$1,122.599$599.674$514.179$372.776$283.703
Cost Of Goods Sold$11.947$4.384$1.82---
Gross Profit$717.317$1,118.215$597.854$514.179$372.776$283.703
Research And Development Expenses$535.077$465.688$414.604$374.644$344.32$322.292
SG&A Expenses$354.322$286.644$244.622$108.488$48.616$37.173
Other Operating Income Or Expenses------
Operating Expenses$901.346$756.716$661.046$483.132$392.936$359.465
Operating Income$-172.082$365.883$-61.372$31.047$-20.16$-75.762
Total Non-Operating Income/Expense$2.05$-19.114$-14.784$-47.81$-37.306$-12.144
Pre-Tax Income$-170.032$346.769$-76.156$-16.763$-57.466$-87.906
Income Taxes$316.734$43.507$-291.141$-5.98$2.934$0.372
Income After Taxes$-486.766$303.262$214.985$-10.783$-60.4$-88.278
Other Income------
Income From Continuous Operations$-486.766$303.262$214.985$-10.783$-60.4$-88.278
Income From Discontinued Operations------
Net Income$-451.286$294.146$273.741$0.346$-60.4$-88.278
EBITDA$-104.666$413.672$-14.684$82.343$27.494$-27.839
EBIT$-172.082$365.883$-61.372$31.047$-20.16$-75.762
Basic Shares Outstanding140140132124121120
Shares Outstanding140143134126121120
Basic EPS$-3.23$2.12$2.09$0.15$-0.50$-0.74
EPS - Earnings Per Share$-3.23$2.08$2.07$0.15$-0.50$-0.74
# 2020 2019 2018 2017 2016 2015
Current Ratio3.65329.96547.8774.79755.96435.6221
Long-term Debt / Capital0.390.3180.34780.62390.83810.7228
Debt/Equity Ratio0.99550.46750.54481.6635.192.653
Gross Margin98.361899.609599.6965100100100
Operating Margin-23.596732.5925-10.23426.0382-5.4081-26.7047
EBIT Margin-23.596732.5925-10.23426.0382-5.4081-26.7047
EBITDA Margin-14.352336.8495-2.448716.01457.3755-9.8127
Pre-Tax Profit Margin-23.315630.8898-12.6996-3.2601-15.4157-30.9852
Net Profit Margin-61.882426.202245.64830.0673-16.2028-31.1163
Asset Turnover0.30520.34720.22480.38870.40850.2993
Inventory Turnover Ratio0.54390.24110.2121---
Receiveable Turnover9.569917.809447.00018.16743.450324.9827
Days Sales In Receivables38.140520.49487.765944.6898105.789314.6101
ROE - Return On Equity-57.718418.002618.1092-2.952-60.6639-43.9653
Return On Tangible Equity-59.695918.281218.4834-3.1412-76.2626-48.645
ROA - Return On Assets-20.36899.37998.0586-0.8152-6.6194-9.313
ROI - Return On Investment-35.210212.277611.8115-1.1103-9.8191-12.1853
Book Value Per Share6.008212.00348.6072.92280.81851.6684
Operating Cash Flow Per Share-2.162-2.07833.11632.3081-1.10350.1231
Free Cash Flow Per Share-2.1973-2.19313.29052.0912-1.0980.1227

Porovnání s konkurencí: Akcie IONS

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
IONS N/A 25.70 -26.88 % 118.18 % -62.12 % 5.76 -61.88 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %

Nedávné obchody insiderů: Akcie IONS

Jméno Obchod Cena Objem
Eugene Schneider
EVP and Chf Clinical Develop Offc
Option
15 Jan 2021
$61.28 $459,784
B Lynne Parshall
Director
Option
15 Jan 2021
$61.28 $652,938
Brett P Monia
Chief Executive Officer
Option
15 Jan 2021
$61.28 $2,133,953
Elizabeth L Hougen
EVP, Finance, and CFO
Option
15 Jan 2021
$61.28 $1,051,013
Richard S Geary
EVP and Chief Development Offc
Option
15 Jan 2021
$61.28 $1,078,405
C Frank Bennett
Chief Scientific Officer
Option
15 Jan 2021
$61.28 $951,066
Stanley T Crooke
Exec Chairman of the Board
Option
15 Jan 2021
$61.28 $3,163,764
Stanley T Crooke
Exec Chairman of the Board
Prodej
21 Jan 2021
$61.45 $4,608,750
Stanley T Crooke
Exec Chairman of the Board
Prodej
26 Jan 2021
$63.74 $1,805,945
Eugene Schneider
EVP and Chf Clinical Develop Offc
Option
15 Jan 2021
$61.28 $459,784
B Lynne Parshall
Director
Option
15 Jan 2021
$61.28 $652,938
Brett P Monia
Chief Executive Officer
Option
15 Jan 2021
$61.28 $2,133,953
Elizabeth L Hougen
EVP, Finance, and CFO
Option
15 Jan 2021
$61.28 $1,051,013
Richard S Geary
EVP and Chief Development Offc
Option
15 Jan 2021
$61.28 $1,078,405
C Frank Bennett
Chief Scientific Officer
Option
15 Jan 2021
$61.28 $951,066
Stanley T Crooke
Exec Chairman of the Board
Option
15 Jan 2021
$61.28 $3,163,764
Stanley T Crooke
Exec Chairman of the Board
Prodej
21 Jan 2021
$61.45 $4,608,750
Stanley T Crooke
Exec Chairman of the Board
Prodej
26 Jan 2021
$63.74 $1,805,945

Diskuze k akciím IONS